/R E P E A T -- Notice to Media - Minister of Health to announce support for several initiatives in Atlantic Canada/
OTTAWA, May 9, 2019 /CNW/ -
Friday May 10
The Honourable Ginette Petitpas Taylor, Federal Minister of Health, will attend the New Brunswick Hospice and Palliative Care Conference to announce funding for palliative care. She will also visit West Highlands Elementary School in Amherst to make a funding announcement to support well-being for students in Nova Scotia.
The itinerary of events includes:
Moncton, New Brunswick
8:00 a.m. (ADT): Minister Petitpas Taylor will attend the New Brunswick Hospice and Palliative Care Association's Conference and will announce support to help strengthen palliative care for Canadians.
The Minister will be available to media following her remarks.
Location Delta Beausejour Moncton 750 Main Street Moncton, New Brunswick E1C 1E6
Amherst, Nova Scotia
10:45 a.m. (ADT): Minister Petitpas Taylor will make an announcement on physical activity, healthy eating and the well-being of students in Nova Scotia.
The Minister will be available to media following the announcement.
Location West Highlands Elementary School 18 Maltby Court Amherst, Nova Scotia B4H 2L6
all® free clear, the #1 detergent brand recommended by dermatologists for sensitive skin, today announced it is partnering with Dr. Lindsey Zubritsky ? a board certified dermatologist and one of social media's most-followed...
Innovations in patient care developed at Florida Cancer Specialists & Research Institute, LLC (FCS) will be presented at the Oncology Nursing Society 49th Annual Congress in Washington, DC, the largest global gathering dedicated to oncology nursing....
FORUS Therapeutics Inc. ("FORUS") is deeply disappointed and disagrees with the recent decision by the Honourable Christian Dubé, Minister of Health and Social Services in Quebec to deny listing XPOVIO® (selinexor) in combination with VELCADE®...
The Inception Company, trusted provider of meeting solutions to the life sciences industry and HCPs (healthcare professionals) for over 20 years and known for its Pandotm platform, announces a pivotal role expansion for its in-house Executive...
n-Lorem, a nonprofit foundation, announced a new partnership with Hongene Biotech Corporation that supports n-Lorem's efforts to discover and provide personalized experimental antisense oligonucleotide (ASO) medicines to nano-rare disease patients (1...
Synaptogenix, Inc. ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, today announced that it received notice from The Nasdaq Stock Market LLC ("Nasdaq") on April 22,...
